INCON Co., Ltd. - 12 Dec 2022 Form 4 Insider Report for ZyVersa Therapeutics, Inc. (ZVSA)

Role
10%+ Owner
Signature
/s/ Sung Gon Kim
Issuer symbol
ZVSA
Transactions as of
12 Dec 2022
Net transactions value
$0
Form type
4
Filing time
16 Dec 2022, 20:41:09 UTC
Next filing
03 Aug 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZVSA Common Stock Award $0 +1,497,199 $0.000000 1,497,199 12 Dec 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZVSA Warrant (right to buy) Award $0 +450,702 $0.000000 450,702 12 Dec 2022 Common Stock 450,702 $6.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The warrant is immediately exercisable in full.

Remarks:

The board of directors of INCON Co., Ltd. possesses the shared power to vote or dispose of the shares reported herein. The natural persons on the INCON Co., Ltd. board of directors are Kim Sung-gon, Choi Yeong-hun, Park Jong-jin, Lee Ju-hyeong, and Lee Jeong-uk. No individual possesses the sole power to vote or dispose of such shares reported herein.